NCT06145035View on ClinicalTrials.gov

Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions
Ischemic Heart Disease
Interventions
BIOLOGICAL

umbilical cord-derived mesenchymal stromal cells (UC-MSCs)

The study product will consist of 100 million UC-MSCs suspended in a final volume of 60 ml given at a rate of 3.3 million cells/min. The product will be infused into vein via intravenous line placed in the arm.

Trial Locations (3)

33136

RECRUITING

University of Miami Miller School of Medicine, Miami

40202

RECRUITING

University of Louisville School of Medicine, Institute of Molecular Cardiology, Louisville

77030

RECRUITING

The Texas Heart Institute Houston Texas, Houston

All Listed Sponsors
collaborator

University of Miami

OTHER

collaborator

University of Texas

OTHER

collaborator

United States Department of Defense

FED

lead

Roberto Bolli

OTHER